Skip to main content
Fig. 4 | Journal of Otolaryngology - Head & Neck Surgery

Fig. 4

From: Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype

Fig. 4

Introduction of PIK3CAE545K led to loss of well-differentiated thyroid cancer markers in vivo. A LAM1EV and LAM1:PIK3CAE545K were implanted in the hind flanks of nude mice. Mice were sacrificed at 14 weeks post-injection and tumours were dissected from flanks and stored in formalin for FFPE preparation and IHC. B Dissected tumours were weighed (mg) for each specimen and compared between the LAM1EV and LAM1:PIK3CAE545K groups. Individual tumour volumes of dissected specimens were calculated using the formula: [length x (width)2] × 0.52 and compared between cell line groups. (C,D) Tumours were collected, stained (C), and quantified (D) to determine relative differences in protein expression of thyroid differentiation markers thyroid transcription factor-1 (TTF-1), PAX8, thyroglobulin and B-catenin between the LAM1EV and LAM1:PIK3CAE545K models

Back to article page